Meryem Grabski

TL;DR: The literature on the prospective association between smoking and depression and anxiety is inconsistent in terms of the direction of association most strongly supported, suggesting the need for future studies that employ different methodologies, such as Mendelian randomization (MR), which will allow for stronger causal inferences.

TL;DR: A single 800‐mg oral dose of cannabidiol reduced the salience and pleasantness of cigarette cues, compared with placebo, after overnight cigarette abstinence in dependent smokers and did not influence tobacco craving or withdrawal or any subjectively rated side effects.

TL;DR: Treatment with three infusions of ketamine was well tolerated in patients with severe alcohol use disorder and was associated with more days of abstinence from alcohol at 6-month follow-up, suggesting a possible beneficial effect of adding psychological therapy alongside ketamine treatment.

TL;DR: A single 800 mg dose of CBD does not improve verbal or spatial working memory, or impulsivity during tobacco abstinence, and a Bayesian analysis found evidence for the null hypothesis.

TL;DR: The results suggest that the CADSS total is not consistently associated with antidepressant outcomes, and the current literature is too limited to draw definite conclusions on the presence of an association between acute psychoactive effects and mental health outcomes.